Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Diamyd Medical Aktiebolag
AB
Active
Org 5562423797
Kungsgatan 29, 111 56
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 1984
20-49 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Diamyd Medical Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
-24M
-49M
-73M
-98M
-85M
2021
-111M
2022
-112M
2023
-143M
2024
-177M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
253
506
690
605
525
Staff expenses
—
—
—
—
—
EBITDA
−85 098
−110 957
−111 992
−143 326
−177 089
Depreciation & amort.
−782
−2 503
−3 466
−3 657
−4 388
EBIT
−85 880
−113 460
−115 458
−146 983
−181 477
Net financials
145 926
11 079
−6 449
−25 923
13 745
Profit before tax
60 046
−102 381
−121 906
−160 991
−167 225
Tax
−0
−0
−0
−0
−0
Net profit
60 046
−102 381
−121 906
−160 991
−167 225
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
201 438
249 070
212 071
216 130
354 211
Equity
189 258
229 033
178 217
145 599
282 230
Long-term debt
0
0
15 865
30 672
45 043
Short-term debt
11 402
19 260
17 296
39 438
26 824
Total debt
11 402
19 260
33 161
70 110
71 867
Financial ratios
5-year trend
EBITDA margin
-33731.2%
This company
15.8%
Market median
-213589% vs market
2021
2025
Equity ratio
79.7%
This company
38.2%
Market median
+109% vs market
2021
2025
Return on equity
-59.3%
This company
18.4%
Market median
-422% vs market
2021
2025
Net profit margin
-31852.4%
This company
8.1%
Market median
-393340% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
More on Diamyd Medical Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
